Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind study evaluating T-614 in combination with methotrexate in rheumatoid arthritis patients with inadequate MTX response; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• T-614 (t-614)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-06-19